... Cancer Pregnancy Alcohol intake Original Paper Haemostasis 1994;24:175-182 J.F. Schved C. Dupuy-Fons1 C. Birorf I. Quereb C. Janbonb a Laboratory of Haematology, and b Department of Internal Medicine Hopitai Saint-Eloi, University Hospital. Montpellier. France A Prospective Epidemiological Study...

... subjects (age range 17-74 years – group A), in 57 acute patients (age range 17-79 years – group B) and in 14 pregnant women (age range 27-41 years, pregnancy weeks 30-40 – group C), as a physiologic model of hyperfibrinogenemia. CFg was assayed on citrated plasma by the Clauss clotting method and IFg...

... of patients so they are not exposed to the risks of anticoagulants. The diagnosis of DVT and PE during pregnancy is problematic. The use of invasive diagnostic tests, such as venography and pulmonary angiography, is limited because of the potential risks to the fetus of radiation exposure. Due to hemodynamic...

... from any ideas, methods, instructions or products referred to in the content or advertisements. Pregnancy coagulation factors Haemostasis 1996; 26 (Suppl 4): 244-247 HEMOSTASIS DURING PREGNANCY AND PUERPERIUM. Margareta Hellgren, MD, Ph.D., Department of Obstetrics and Gynecology, Molndal...

...J. Harenberg; D. Schneider; L. Heilmann; H. Wolf Prophylaxis of thromboembolism with low molecular mass (LMM) heparin may offer several advantages over conventional heparin during pregnancy. Heparin-related side effects as osteoporosis, local allergy, thrombocytopenia and increase in liver enzymes...

... platelet aggregation was seen throughout pregnancy. In order to estimate the clinical value of the test in pregnancy, we followed up a number of pregnant patients with primary enhanced spontaneous whole-blood platelet aggregation before and after treatment with low-dose acetylsalicylic acid. The test...

.... Tamuraa , M. Maegawab, M. Kamadah, M. Takayanagib Departments of Internal Medicine and bObstetrics and Gynecology, Kagawa Prefectural Tsuda Hospital, Kagawa, Japan Key Words. Antithrombin III activity Congenital antithrombin III deficiency Fibrinopeptide A Hemostatic molecular markers Pregnancy...

... observed that heparin clearance is increased during pregnancy. Pregnancy Heparin-dipyridamole Blood clotting parameters Platelet aggregation 25 02 1983 27 04 1983 21 4 2009 © 1983 S. Karger AG, Basel 1983 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved...

...Ernest Briet; Howard M. Reisner; Philip M. Blatt The levels of factors VIII, II, and VII rise during pregnancy in normal women. In addition, increases in factor VIII levels have been observed in pregnant carriers of hemophilia A and in women affected with von Willebrand’s disease. The influence...

...Rosario Russo; Uberto Bortolotti; Luciano Schivazappa; Antonio Girolami The case history is presented of a woman aged 38 who received warfarin treatment because of a mitral valve replacement. During the first trimester of pregnancy, her prothrombin time was 20% of normal and kept at 40% until...

...Inge Clemmensen; Sixtus Thorsen; Sten Müllertz An inhibitor of urokinase present in increased concentrations in plasma during pregnancy was purified. The inhibitor was identified by its pronounced effect on urokinase-induced fibrinolysis as opposed to the absence of effect on fibrinolysis induced...

...Wee Shian Chan Women with mechanical heart valves require anticoagulation during pregnancy. Continued anticoagulation with coumadin throughout the first trimester can result in foetopathic effects in 6.4% (95% CI, 4.6–8.9%) of cases. Replacement of warfarin with heparin between 6 and 12 weeks...

...Jacqueline Conard; Marie-Hélène Horellou; Meyer-Michel Samama Hereditary thrombophilia increases the risk of thrombosis during pregnancy and postpartum. The recommendations resulting from the Fifth American College of Chest Physicians (ACCP) Consensus Conference on Antithrombotic Therapy were...

.... Unfractionated heparin has been used to a limited extent in these situations and requires dose adjustment in order to achieve an acceptable efficacy. Low-molecular-weight heparin (LMWH) is a valuable alternative to warfarin for these patients and for thromboprophylaxis during pregnancy. In several subgroups...

...Ian A. Greer Pulmonary thromboembolism remains a major cause of maternal death in the Western world. The frequency of antepartum deaths, including deaths in the first and second trimester, which can be associated with early pregnancy problems such as hyperemesis, is similar in number to the deaths...

...Shannon M. Bates Venous thromboembolism (VTE) is an important cause of obstetric morbidity and mortality. Its management during pregnancy is problematic because anticoagulants, the cornerstone of initial therapy for VTE, may have significant foetal as well as maternal side effects. Unfractionated...

... fixed dosages throughout the pregnancy or dosages adapted to the gestational age. We tested whether monitoring thromboprophylaxis with D-dimers and thrombin-antithrombin complexes (TAT) would provide additional information on the optimal dose of LMW heparin. Women (165 women and 202 pregnancies...

.... Only English language publications were included. Event rates for venous thromboembolism and death were pooled using a random effect technique. Reports of paroxysmal nocturnal hemoglobinuria during pregnancy were summarized using descriptive statistics only. Results: Thirteen retrospective studies...